Effective biliary drainage and proper treatment improve outcomes of hepatocellular carcinoma with obstructive jaundice

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background/Aims: We investigated the treatment outcomes and prognostic factors of hepatocellular carcinoma (HCC) with obstructive jaundice. Methods: Among 2,861 patients newly diagnosed with HCC between 2002 and 2011, a total of 63 patients who initially presented with obstructive jaundice were analyzed. Only four patients presented with resectable tumors and underwent curative resection. In the other patients who presented with unresectable tumors, 5, 8, 9, and 18 patients received transarterial chemoembolization (TACE), chemotherapy, radiotherapy, and combined treatment, respectively. Both the clinical and the treatment factors that affect overall survival (OS) were analyzed. Results: The median OS was 4 months, and the 1-year OS rate was 23%. Patients who received treatment for HCC had a significantly improved OS rate compared with the patients who received supportive care only (1-year OS, 32% vs 0%; p<0.01). Responders to treatment showed a better OS than nonresponders (1-year OS, 52% vs 0%; p<0.01). TACE and radiotherapy resulted in relatively good treatment responses of 64% and 67%, respectively. In multivariate analyses, treatment of HCC (p=0.02) and the normalization of serum bilirubin by biliary drainage (p=0.02) were significantly favorable prognostic factors that affected the OS. Conclusions: Unresectable HCC with obstructive jaundice has a poor prognosis. However, effective biliary drainage and treatment of HCC such as with TACE or radiotherapy improves survival.

Original languageEnglish
Pages (from-to)526-535
Number of pages10
JournalGut and liver
Volume8
Issue number5
DOIs
Publication statusPublished - 2014 Jan 1

Fingerprint

Obstructive Jaundice
Drainage
Hepatocellular Carcinoma
Survival
Radiotherapy
Therapeutics
Survival Rate
Bilirubin
Neoplasms
Multivariate Analysis
Drug Therapy
Serum

All Science Journal Classification (ASJC) codes

  • Hepatology
  • Gastroenterology

Cite this

@article{8d64d35681ae40ffb2b4a04e0ec3a277,
title = "Effective biliary drainage and proper treatment improve outcomes of hepatocellular carcinoma with obstructive jaundice",
abstract = "Background/Aims: We investigated the treatment outcomes and prognostic factors of hepatocellular carcinoma (HCC) with obstructive jaundice. Methods: Among 2,861 patients newly diagnosed with HCC between 2002 and 2011, a total of 63 patients who initially presented with obstructive jaundice were analyzed. Only four patients presented with resectable tumors and underwent curative resection. In the other patients who presented with unresectable tumors, 5, 8, 9, and 18 patients received transarterial chemoembolization (TACE), chemotherapy, radiotherapy, and combined treatment, respectively. Both the clinical and the treatment factors that affect overall survival (OS) were analyzed. Results: The median OS was 4 months, and the 1-year OS rate was 23{\%}. Patients who received treatment for HCC had a significantly improved OS rate compared with the patients who received supportive care only (1-year OS, 32{\%} vs 0{\%}; p<0.01). Responders to treatment showed a better OS than nonresponders (1-year OS, 52{\%} vs 0{\%}; p<0.01). TACE and radiotherapy resulted in relatively good treatment responses of 64{\%} and 67{\%}, respectively. In multivariate analyses, treatment of HCC (p=0.02) and the normalization of serum bilirubin by biliary drainage (p=0.02) were significantly favorable prognostic factors that affected the OS. Conclusions: Unresectable HCC with obstructive jaundice has a poor prognosis. However, effective biliary drainage and treatment of HCC such as with TACE or radiotherapy improves survival.",
author = "Suh, {Yang Gun} and doyoung kim and KwangHyub Han and Jinsil Seong",
year = "2014",
month = "1",
day = "1",
doi = "10.5009/gnl13370",
language = "English",
volume = "8",
pages = "526--535",
journal = "Gut and Liver",
issn = "1976-2283",
publisher = "Joe Bok Chung",
number = "5",

}

TY - JOUR

T1 - Effective biliary drainage and proper treatment improve outcomes of hepatocellular carcinoma with obstructive jaundice

AU - Suh, Yang Gun

AU - kim, doyoung

AU - Han, KwangHyub

AU - Seong, Jinsil

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Background/Aims: We investigated the treatment outcomes and prognostic factors of hepatocellular carcinoma (HCC) with obstructive jaundice. Methods: Among 2,861 patients newly diagnosed with HCC between 2002 and 2011, a total of 63 patients who initially presented with obstructive jaundice were analyzed. Only four patients presented with resectable tumors and underwent curative resection. In the other patients who presented with unresectable tumors, 5, 8, 9, and 18 patients received transarterial chemoembolization (TACE), chemotherapy, radiotherapy, and combined treatment, respectively. Both the clinical and the treatment factors that affect overall survival (OS) were analyzed. Results: The median OS was 4 months, and the 1-year OS rate was 23%. Patients who received treatment for HCC had a significantly improved OS rate compared with the patients who received supportive care only (1-year OS, 32% vs 0%; p<0.01). Responders to treatment showed a better OS than nonresponders (1-year OS, 52% vs 0%; p<0.01). TACE and radiotherapy resulted in relatively good treatment responses of 64% and 67%, respectively. In multivariate analyses, treatment of HCC (p=0.02) and the normalization of serum bilirubin by biliary drainage (p=0.02) were significantly favorable prognostic factors that affected the OS. Conclusions: Unresectable HCC with obstructive jaundice has a poor prognosis. However, effective biliary drainage and treatment of HCC such as with TACE or radiotherapy improves survival.

AB - Background/Aims: We investigated the treatment outcomes and prognostic factors of hepatocellular carcinoma (HCC) with obstructive jaundice. Methods: Among 2,861 patients newly diagnosed with HCC between 2002 and 2011, a total of 63 patients who initially presented with obstructive jaundice were analyzed. Only four patients presented with resectable tumors and underwent curative resection. In the other patients who presented with unresectable tumors, 5, 8, 9, and 18 patients received transarterial chemoembolization (TACE), chemotherapy, radiotherapy, and combined treatment, respectively. Both the clinical and the treatment factors that affect overall survival (OS) were analyzed. Results: The median OS was 4 months, and the 1-year OS rate was 23%. Patients who received treatment for HCC had a significantly improved OS rate compared with the patients who received supportive care only (1-year OS, 32% vs 0%; p<0.01). Responders to treatment showed a better OS than nonresponders (1-year OS, 52% vs 0%; p<0.01). TACE and radiotherapy resulted in relatively good treatment responses of 64% and 67%, respectively. In multivariate analyses, treatment of HCC (p=0.02) and the normalization of serum bilirubin by biliary drainage (p=0.02) were significantly favorable prognostic factors that affected the OS. Conclusions: Unresectable HCC with obstructive jaundice has a poor prognosis. However, effective biliary drainage and treatment of HCC such as with TACE or radiotherapy improves survival.

UR - http://www.scopus.com/inward/record.url?scp=84906213822&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84906213822&partnerID=8YFLogxK

U2 - 10.5009/gnl13370

DO - 10.5009/gnl13370

M3 - Article

VL - 8

SP - 526

EP - 535

JO - Gut and Liver

JF - Gut and Liver

SN - 1976-2283

IS - 5

ER -